fbpx

Latest news

DoseMe Joins Tabula Rasa HealthCare
8 Jan 2019 | Latest News

DoseMe Joins Tabula Rasa HealthCare

Tabula Rasa HealthCare (TRHC) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, has completed its acquisition of DoseMe on January 2, 2019. DoseMeRx’s precision dosing capabilities will join TRHC's suite of technology and consulting services for healthcare organizations, 

Read more
Vancomycin IV Dosing in Pediatrics
19 Dec 2018 | Blog

Vancomycin IV Dosing in Pediatrics

Vancomycin is a commonly prescribed antibiotic used to treat children and adults with serious infections. Here we review some of the most common indications for vancomycin use and important safety considerations for health practitioners using this drug in pediatric patients. We discuss dosing guidelines, monitoring...

Read more
Tabula Rasa HealthCare to Acquire DoseMe
4 Dec 2018 | Latest News

Tabula Rasa HealthCare to Acquire DoseMe

DoseMe, the first company in the world to design a precision dosing platform - DoseMeRx - specifically developed for clinical practice today announced it will be acquired by Tabula Rasa HealthCare, Inc (NASDAQ:TRHC) a healthcare technology company advancing the field of medication safety. Tabula Rasa HealthCare (“TRHC”)...

Read more
Texas Children’s & Houston Methodist Vizient Webinar
15 Nov 2018 | Blog

Texas Children’s & Houston Methodist Vizient Webinar

Earlier this month, Dr William Musick, Director of the PGY2 Infectious Diseases Pharmacy Residency program at Houston Methodist and Dr. Ryan Keul, Clinical Pharmacy Specialist for Antibiotic Stewardship at Texas Children's Hospital shared their experience with DoseMeRx for vancomycin monitoring and a case study on busulfan dosing during a...

Read more

HIPAA Privacy Statement | Privacy policy | DoseMe & the GDPR | Copyright © 2012 - 2019 DoseMe Pty Ltd. All Rights Reserved.
DoseMe® is a registered trademark of DoseMe Pty Ltd. DoseMeRx℠ and DoseMe℞℠ are service marks of DoseMe LLC.